Introduction to quality engineering....
International Journal of Rheumatic DiseasesPublished 28 September 2014
Genichi Taguchi
Citations645
SJR quartileQ3
SJR score0.58
SNIP0.68
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
There were no significant differences in efficacy and safety between ADA combined with TwHF versus ADA combined with MTX in the treatment of RA. TwHF might be an alternative treatment for RA patients who are intolerant to MTX.
Keywords
Business, Management and Accounting
Annals of the Rheumatic Diseases2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
4,875 Citations2010D. Aletaha, Tuhina Neogi +33 more
Arthritis & RheumatismThe PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
1,786 Citations2005Ferdinand C. Breedveld, Michael H. Weisman +7 more
Combination therapy with adalimumab plus MTX was significantly superior to either MTX alone or ad alimumab alone in improving signs and symptoms of disease, inhibiting radiographic progression, and effecting clinical remission in patients with early, aggressive rheumatoid arthritis.
International Journal of Molecular SciencesThe Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
1,621 Citations2021Dan-in Jang, A-Hyeon Lee +6 more
The impact of TNF-α signaling on autoimmune diseases and its inhibitors, which are used as therapeutic agents against autoimmune diseases, are briefly introduced.
Arthritis Care & Research2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
1,284 Citations2021Liana Fraenkel, Joan M. Bathon +35 more
To develop updated guidelines for the pharmacologic management of rheumatoid arthritis, a database of clinical practice and animal studies was developed.
The LancetNovel treatment strategies in rheumatoid arthritis
1,009 Citations2017Gerd R Burmester, Janet Pope
New insights into the management of rheumatoid arthritis with targeted therapy approaches using classic and novel medications are described, and the potential effects of precision medicine in this challenging disease are outlined.
Nature Reviews RheumatologyMethotrexate and its mechanisms of action in inflammatory arthritis
599 Citations2020Bruce N. Cronstein, Thomas M. Aune
Methotrexate inhibits important pro-inflammatory properties of major cell lineages involved in rheumatoid arthritis pathogenesis, including T cells, macrophages, endothelial cells and fibroblast-like synoviocytes, by modulating cell-specific signalling pathways.
Arthritis & RheumatismA randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
388 Citations2012Larry W. Moreland, James R. O’Dell +11 more
Initial use of MTX monotherapy with the addition of sulfasalazine plus hydroxychloroquine (or etanercept, if necessary, after 6 months) is a reasonable therapeutic strategy for patients with early RA.
Annals of the Rheumatic DiseasesEULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
276 Citations2021György Nagy, Nadia M T Roodenrijs +30 more
These PtCs for D2T RA can serve as a clinical roadmap to support healthcare professionals and patients to deliver holistic management and more personalised pharmacological and non-pharmacological therapeutic strategies.
The LancetAdjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
272 Citations2013Josef S Smolen, Paul Emery +9 more
Treatment to a stable low disease activity target resulted in improved clinical, functional, and structural outcomes, with both adalimumab-continuation and methotrexate-monotherapy.
The Journal of RheumatologyThe Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies
232 Citations2020Khalid Almutairi, Johannes C. Nossent +3 more
The population database studies were more consistent than sampling studies, and linked databases in different continents appeared to provide a consistent estimate of RA period prevalence, confirming the high value of rheumatologist diagnosis as classification criteria.
Annals of the Rheumatic DiseasesLong term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
214 Citations2005Michael E. Weinblatt, E C Keystone +4 more
Adalimumab plus MTX sustained clinical response and remission in patients with RA during 4 years and the safety profile during the first 6 months was similar to that after 4 years’ follow up.
Annals of the Rheumatic DiseasesInduction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
186 Citations2012J. Detert, H. Bastian +16 more
A greater reduction in radiographic progression after initial combination therapy with ADA and MTX was seen at week 48, even after discontinuation of ADA treatment at week 24, while a sustained effect was not found at the primary outcome (DAS28 reduction).
Rheumatology InternationalA Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety
166 Citations2011Jun Bao, Sheng‐Ming Dai
The immunosuppressive, cartilage protective, and anti-inflammatory effects of TwHF extracts are well demonstrated, and TwHF extract is an alternative disease modifying anti-rheumatic drug (DMARD) for the patients with RA refractory to conventional therapy.
International Journal of Molecular SciencesNatural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome
160 Citations2018Steven Dudics, David Langan +5 more
It is believed that with several advances in the past decade in the characterization and functional studies of natural products, the stage is set for widespread clinical testing and/or use of these products for the treatment of RA and other diseases.
Frontiers in PharmacologyClinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
135 Citations2021Na Lin, Yanqiong Zhang +22 more
Recommendations and experts' suggestions in this guideline summarized the clinical indications, usage, dosage, combined medication, and safety of TGT and TWT against RA systematically and comprehensively, which may offer a professional guidance in the context of the clinical application of the two TwHF-based agents.
FitoterapiaThe genus Tripterygium: A phytochemistry and pharmacological review
105 Citations2019Huawei Lv, Liangping Jiang +7 more
This work provides structurally grouping statistic of 198 secondary metabolites of Tripterygium species published from 2008 to the present, as well as pharmacological knowledges in the past five years that will be helpful for developing the new discoveries of medicinal value related to this genus.
BMJTumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial
89 Citations2015D L Scott, Fowzia Ibrahim +10 more
In patients with active rheumatoid arthritis who meet English criteria for biologics an alternative strategy with combinations of intensive synthetic disease modifying drugs gives non-inferior outcomes to treatment with tumour necrosis factor inhibitors.
International Journal of Rheumatic DiseasesBurden of rheumatoid arthritis from a societal perspective: A prevalence‐based study on cost of this illness for patients in China
70 Citations2017Hao Hu, Luan Luan +2 more
To provide a comprehensive estimation of the economic burden of rheumatoid arthritis in China, especially for patients from less developed areas, and to explore the cost transferability between regions to assist healthcare decision‐making.
BMC Complementary and Alternative MedicineTripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis
55 Citations2016Hailong Wang, Quan Jiang +6 more
The data suggest that TwHF is effective and safe in the treatment of RA and has better clinical efficacy in terms of ACR 20 and 50 than existing conventional synthetic DMARDs.
BMC Complementary and Alternative MedicineEfficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis
31 Citations2018Liu Liu, Huaibo Zhao +10 more
Large sample, multi-center, high-quality clinical studies are needed to verify the exact effects and safety of TwHF and Tripterygium agents in treatment of chronic urticaria, as they appear to be more effective than antihistamines alone.
Current Opinion in PharmacologyDrug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors
30 Citations2020Kai Xi Zhang, Chi Kio Ip +5 more
The role of p53 gene mutations, ABC family transporters and personal factors in antirheumatic drug-resistance, which may lead to new personalized therapies against RA with an increased drug-sensitivity, is highlighted.
Journal of Clinical MedicineIncreased Risk of Hypothyroidism in People with Asthma: Evidence from a Real-World Population-Based Study
27 Citations2022Shih-Cheng Huang, Shuo‐Yan Gau +3 more
Having asthma to be associated with an increased risk of hypothyroidism is found, and Clinicians should be concerned regarding the endocrinological and inflammatory interaction between the two diseases while caring for people with asthma.
PubMed CentralComparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis: A Randomized Trial
19 Citations2009Goldbach-Mansky, Raphaela, Wilson, Mildred +15 more
European Journal of Preventive CardiologyTramadol use increases mortality and risk of major adverse cardiovascular events in rheumatoid arthritis patients: evidence from a population-based cohort study
18 Citations2021Shuo‐Yan Gau, Jing‐Yang Huang +1 more
International Journal of Rheumatic DiseasesRheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of rheumatic diseases
18 Citations2021Arvind Chopra, Hsiao‐Yi Lin +9 more
Virtual meetings were conducted in mid-2020 to explore perspectives of rheumatologists and patients, as well as discuss the impact of coronavirus disease 2019 on RA management.
Queensland's institutional digital repository (The University of Queensland)Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): A randomised, controlled clinical trial
17 Citations2015Lv, Qian-Wen, Zhang, Wen +29 more
International Journal of Rheumatic DiseasesTraditional Chinese medicine in the treatment of patients with hyperuricemia: A randomized <scp>placebo‐controlled double‐blinded</scp> clinical trial
14 Citations2023Pui‐Ying Leong, Huang‐Hsi Chen +4 more
Identifying a safe and effective alternative to traditional Chinese medicine for treating hyperuricemia is essential for treating hyperuricemia and gout.
International Journal of Rheumatic DiseasesThe association of disease activity with depression and sleep quality in patients with rheumatoid arthritis in Hong Kong
9 Citations2023Shuk Yi Lucia Chau, Moon Ho Alexander Leung +1 more
Clinicians should be aware of mood and sleep problems in patients with RA and adopt a multidisciplinary approach to their management, and the association of BDI‐II with DAS28‐ESR and PSQI was confounded by the HAQ.
International Journal of Rheumatic DiseasesProton pump inhibitor use associated with an increased risk of gout: A population‐based case–control study
9 Citations2023Kai‐Jun Zhu, Wei Feng +6 more
Examination of the potential impact of PPI treatment on the risk of developing gout found no evidence of an association between PPI use and gout diagnosis.